PerpTools – How DEXTools Is Building the Full DeFi Trading Stack

PerpTools – How DEXTools Is Building the Full DeFi Trading Stack

From The Crypto Conversation by Brave New Coin

March 31, 2026 · 22 min

About this episode

Wael Rajab discusses how DEXTools is expanding its offerings with PerpTools to enhance DeFi trading.

Wael Rajab is the CMO of PerpTools and co-founder and director of DEXT Ventures, the capital arm of DEXTools — one of DeFi's original and most widely used on-chain trading and analytics platforms. With nearly a decade in crypto and a portfolio spanning over 100 investments across 150+ integrated blockchains, Wael has been at the centre of decentralised finance's growth from data dashboard to full trading stack. Why you should listen DEXTools built its reputation as the go-to platform for on-chain token analytics — the place traders head when they want to understand what's happening across chains without needing to be technically fluent. But the landscape has shifted dramatically. DEX volumes have grown nearly eightfold in two years, from $81 billion to roughly $740 billion, and perpetuals trading has become one of the most contested battlegrounds in DeFi. PerpTools is DEXTools' answer: a native perps vertical that gives millions of existing users the ability to trade derivatives without ever leaving the platform they already trust. What makes the PerpTools story compelling isn't just the product — it's the distribution. Most new perp DEXs face a brutal cold-start problem…

People in this episode

Guest: Wael Rajab

Topics covered

  • DeFi
  • trading
  • analytics
  • cryptocurrency
  • perpetuals
  • user acquisition

Keywords

  • DEXTools
  • PerpTools
  • decentralized finance
  • trading stack
  • crypto investments
  • on-chain analytics
  • derivatives trading

Mentioned in this episode

Organizations: PerpTools, DEXTools, DEXT Ventures, Orderly

More episodes of The Crypto Conversation

Explore listener stats, chart rankings, contacts and more on the The Crypto Conversation podcast page.